Date:2/8/2010

9,995) 29,808 Other expenses -- (26,975) (39,510) (54,695) Total other expenses (10,443) (11,411) (59,505) (24,887) Income before provision for income tax 3,141,317 2,465,947 5,837,975 4,615,789 Provision for income tax 571,756 408,827 1,081,691 767,677 Net income 2,569,561 2,057,120 4,756,284 3,848,112 Less: Net income attributable to noncontrolling interest 1,485 -- (1,040) -- Net income attributable to Tianyin 2,568,076 2,057,120 4,757,324 3,848,112 Other comprehensive income Foreign currency translation adjustment 10,927 256,933 46,784 346,367 Comprehensive income $2,579,003 $2,314,053 $4,804,108 $4,194,479 Basic earnings per share $0.10 $0.11 $0.20 $0.20 Diluted earnings per share $0.08 $0.13 $0.17 $0.16 Weighted average number of common shares outstanding Basic 24,906,965 15,691,495 22,323,116 15,637,623 Diluted 30,439,912 15,691,495 28,521,127 24,697,018 Consolidated Statements of Cash Flows (Unaudited) For the Six Months Ended December 31, 2009 2008 Cash flows from operating activities: Net Income $4,757,324 $3,848,112 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization 393,575 237,619 Noncontro
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
2. Tianyin Pharmaceutical Co., Inc. to Host Fiscal 2009 Earnings Conference Call on Thursday, September 24, 2009 at 10:30 a.m. ET
3. Tianyin Pharmaceutical Co., Inc. Obtains GMP Certification for Its New Production Facility
4. Tianyin Pharmaceutical, Co. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11 at 10:50 am ET
5. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Sanqi Tablets and Yinqiao Jiedu Tablets
6. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
7. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
8. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
9. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
10. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
11. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST